Knockdown of ubiquitin protein ligase E3A affects proliferation and invasion, and induces apoptosis of breast cancer cells through regulation of annexin A2

Zhou,Xiaofang; Deng,Shishan; Liu,Hai; Liu,Yang; Yang,Zhengwei; Xing,Tianyong; Jing,Baoqian; Zhang,Xiaoming

doi:10.3892/mmr.2015.3549

Knockdown of ubiquitin protein ligase E3A affects proliferation and invasion, and induces apoptosis of breast cancer cells through regulation of annexin A2

Authors:
- Xiaofang Zhou
- Shishan Deng
- Hai Liu
- Yang Liu
- Zhengwei Yang
- Tianyong Xing
- Baoqian Jing
- Xiaoming Zhang
View Affiliations

Affiliations: Department of Anatomy, North Sichuan Medical College, Nanchong, Sichuan 637007, P.R. China, Department of Otolaryngology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637007, P.R. China , Morphometric Research Laboratory, North Sichuan Medical College, Nanchong, Sichuan 637007, P.R. China , Department of General Surgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637007, P.R. China , Institute of Immunology and Molecular Biology, North Sichuan Medical College, Nanchong, Sichuan 637007, P.R. China , Sichuan Key Laboratory of Medical Imaging, North Sichuan Medical College, Nanchong, Sichuan 637007, P.R. China
Published online on: March 26, 2015 https://doi.org/10.3892/mmr.2015.3549
Pages: 1107-1113

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study used RNA interference (RNAi) to study how the expression of annexin A2 was affected by ubiquitin protein ligase E3A (UBE3A). In addition, the proliferation, apoptosis and invasiveness of BT‑549 breast cancer cells was studied following knockdown of UBE3A. Three pairs of small interfering RNA (siRNA) fragments targeting UBE3A were designed and transfected into the BT‑549 cells. The effects of silencing UBE3A were detected by reverse transcription‑polymerase chain reaction and western blotting, and the same methods were used to detect the expression levels of annexin A2. Cell proliferation was determined using the Cell Counting kit‑8, and flow cytometry and a Transwell chamber assay were used to assess the rate of cell apoptosis and invasion, respectively. Following transfection with the three siRNAs targeting UBE3A for 72 h, the mRNA expression levels of UBE3A were downregulated, as compared with those in the untreated groups, and siRNA1 was the shown to be the most effective siRNA for silencing UBE3A expression. The protein expression levels were concordant with the mRNA expression levels of UBE3A. In addition, the mRNA and protein expression levels of annexin A2 were downregulated. Cellular proliferation and invasion of the siRNA1 group was inhibited as compared with those in the untreated groups, and apoptosis of UBE3A‑siRNA1 cells was increased as compared with that in the untreated groups. The results of the present study indicated that UBE3A may regulate the expression of annexin A2, resulting in promotion of proliferation and invasion and suppression of apoptosis in BT‑549 cells.

View Figures

View References

1	Yamamoto Y, Huibregtse JM and Howley PM: The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics. 41:263–266. 1997. View Article : Google Scholar : PubMed/NCBI
2	Scheffner M, Huibregtse JM, Vierstra RD and Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:495–505. 1993. View Article : Google Scholar : PubMed/NCBI
3	Khan OY, Fu G, Ismail A, et al: Multifunction steroid receptor coactivator, E6-associated protein, E6-AP is involved in development of the prostate gland. Mol Endocrinol. 20:544–559. 2006. View Article : Google Scholar
4	Xiu XX, Zhang SL, Lu XY, Liang MY, Yu J and Hou JP: SiRNA inhibition of E6AP expression in cervical cancer cells. Zhonghua Bing Li Xue Za Zhi. 37:822–825. 2008.In Chinese.
5	Ramamoorthy S, Tufail R, Hokayem JE, et al: Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. Breast Cancer Res Treat. 132:97–108. 2012. View Article : Google Scholar
6	Deng S, Zhou H, Xiong R, et al: Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics. Breast Cancer Res Treat. 104:21–30. 2007. View Article : Google Scholar
7	Liu X, Disbrow GL, Yuan H, Tomaic V and Schlegel R: Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes. J Virol. 81:12689–12695. 2007. View Article : Google Scholar : PubMed/NCBI
8	Liu X, Yuan H, Fu B, et al: The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem. 280:10807–10816. 2005. View Article : Google Scholar : PubMed/NCBI
9	Mishra A, Godavarthi SK and Jana NR: UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27. Neurobiol Dis. 36:26–34. 2009. View Article : Google Scholar : PubMed/NCBI
10	Shimoji T, Murakami K, Sugiyama Y, et al: Identification of annexin A1 as a novel substrate for E6AP-mediated ubiquitylation. J Cell Biochem. 106:1123–1135. 2009. View Article : Google Scholar : PubMed/NCBI
11	Ramamoorthy S, Dhananjayan SC, Demayo FJ and Nawaz Z: Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. Mol Endocrinol. 24:2099–2113. 2010. View Article : Google Scholar : PubMed/NCBI
12	Lokman NA, Ween MP, Oehler MK and Ricciardelli C: The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 4:199–208. 2011. View Article : Google Scholar : PubMed/NCBI
13	Sharma MR, Koltowski L, Ownbey RT, Tuszynski G and Sharma MC: Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol. 81:146–156. 2006. View Article : Google Scholar : PubMed/NCBI
14	Deng S, Jing B, Xing T, Hou L and Yang Z: Overexpression of annexin A2 is associated with abnormal ubiquitination in breast cancer. Genomics Proteomics Bioinformatics. 10:153–157. 2012. View Article : Google Scholar : PubMed/NCBI
15	Ramamoorthy S and Nawaz Z: E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nucl Recept Signal. 6:e0062008.PubMed/NCBI
16	Yamasaki L and Pagano M: Cell cycle, proteolysis and cancer. Curr Opin Cell Biol. 16:623–628. 2004. View Article : Google Scholar : PubMed/NCBI
17	Micel LN, Tentler JJ, Smith PG and Eckhardt GS: Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. J Clin Oncol. 31:1231–1238. 2013. View Article : Google Scholar : PubMed/NCBI
18	Dees EC and Orlowski RZ: Targeting the ubiquitin-proteasome pathway in breast cancer therapy. Future Oncol. 2:121–135. 2006. View Article : Google Scholar : PubMed/NCBI
19	Spänkuch-Schmitt B, Bereiter-Hahn J, Kaufmann M and Stredhardt K: Effect of RNA sileneing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Natl Cancer Inst. 94:1863–1877. 2002. View Article : Google Scholar
20	Liu S and Chen ZJ: Expanding role of ubiquitination in NF-κB signaling. Cell Res. 21:6–21. 2011. View Article : Google Scholar
21	Adhikari A and Chen ZJ: Diversity of polyubiquitin chains. Dev Cell. 16:485–486. 2009. View Article : Google Scholar : PubMed/NCBI
22	Sadowski M, Suryadinata R, Tan AR, Roesley SN and Sarcevic B: Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes. IUBMB Life. 64:136–142. 2012. View Article : Google Scholar
23	Lochab S, Pal P, Kanaujiya JK, et al: Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells. Proteomics. 12:1363–1377. 2012. View Article : Google Scholar : PubMed/NCBI
24	Srinivasan S and Nawaz Z: E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth. Biochim Biophys Acta. 1809:119–127. 2011. View Article : Google Scholar :
25	Jiang YH, Armstrong D, Albrecht U, et al: Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 21:799–811. 1998. View Article : Google Scholar : PubMed/NCBI
26	Mishra A and Jana NR: Regulation of turnover of tumor suppressor p53 and cell growth by E6-AP, a ubiquitin protein ligase mutated in Angelman mental retardation syndrome. Cell Mol Life Sci. 65:656–666. 2008. View Article : Google Scholar : PubMed/NCBI